Indivior Announces Q2 2024 Financial Results
Indivior PLC (Nasdaq/LSE: INDV) has announced its financial results for the quarter ending June 30, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Indivior PLC (Nasdaq/LSE: INDV) has announced its financial results for the quarter ending June 30, 2024. The company has made available its earnings release, investor presentation, and webcast on its official website at www.indivior.com. A live webcast presentation is scheduled for 13:00 BST (8:00 am ET), to be hosted by CEO Mark Crossley. Interested parties can access the presentation through a webcast link or by registering for telephonic participation. The event provides an opportunity for investors and analysts to gain insights into Indivior's Q2 2024 financial performance and potentially discuss future outlook and strategies.
Details
News Market Reaction – INDV
The recorded move for INDV in the trading session of this news was +20.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- The earnings release can be found at www.indivior.com/investors
- The investor presentation can be found at www.indivior.com/investors (at 7:00 am ET)
There will be a live webcast presentation at 13:00 BST (8:00 am ET) hosted by Mark Crossley, CEO. The details are below.
Webcast link: https://edge.media-server.com/mmc/p/jpgy4cd9
Participants may access the presentation telephonically by registering with the following link: https://register.vevent.com/register/BIdf08b662a5f24248bf5f8677f59ef713
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD), overdose and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-q2-2024-financial-results-302205638.html
SOURCE Indivior PLC
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.